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Abstract
Among the most promising nanomaterials, metallic nanoparticles with antibacterial and antitumor properties are expected to
open new avenues to fight and prevent various tumours and infectious diseases. The study of bactericidal nanomaterial is partic-
ularly timely considering the recent increase in new resistant strains of bacteria to the most potent antibiotics and the potential
role of bactericidal nanomaterial as anticancer agents. This has promoted the research of the well-known activity of silver ions
and silver-based compounds, including silver nanoparticles. The present work is the study of silver nanoparticles synthesized from
Penicillium  brevicompactum  (MTCC-1999). The colour of the cell filtrate changes to dark brown upon addition of 1 mM AgNO3,
suggesting the formation of silver nanoparticles. These silver nanoparticles (AgNPs) were characterized and analyzed by UV–vis
spectrophotometric analysis, which showed a peak of absorbance at 420 nm. Fourier transform infrared (FTIR) analysis showed
amines and amides that are responsible for the stabilization of AgNPs. To determine the particle size, atomic force microscopy
(AFM) analysis was used, which showed that the nanoparticles are spherical and are 30–50 nm in size. High-resolution transmis-
sion electron microscopy (HRTEM) showed that AgNPs were well dispersed, spherical, and well within the range of 40–50 nm.
These nanoparticles displayed good antibacterial activity and also increased the antibiotic activity of gatifloxacin, tetracycline, and
vancomycin. These nanoparticles were further studied for their anticancer activity and showed high toxicity towards the MCF-7
breast cancer cell line.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.  Introduction
Nanobiotechnology is a promising and advanced area
of science and technology that utilizes noble metals at a
nano-scale level. Nanobiotechnology also has immensebehalf of Taibah University. This is an open access article under the
applications in various sectors of life, especially in
the field of medicine. Silver and silver nanoparticles
are important materials that are used in the fields of
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iomedicine and biotechnology, as well as in industrial
pplications, such as biosensors and catalytic, therapeu-
ic and antibacterial materials [1–3]. Various chemical,
hysical, and biological methods are now available to
ynthesize silver nanoparticles. The biological method
or the synthesis of nanoparticles is preferred over other
ethods because it is inexpensive, free from toxic mate-
ials, safe, and environmentally friendly [4].
Some pathogenic bacteria have become resistant to
arious antibiotics, which can make it challenging to
dentify new antibacterial material that can control bac-
erial resistance. The antibacterial activities of silver and
ilver-based ions are well known [5,6]. Several experts
ave described various applications of nanosilver and
ilver nanoparticles, including for catheters and wound
ealing [7]. Many experts have proposed various mech-
nisms regarding the effect of silver nanoparticles on
acteria and the various target sites where nanoparticles
ttack bacteria. The unique shape, small and controlled
ize, and high surface area give silver nanoparticles time
o interact with the bacterial cell membrane where they
elease metal ions. The metal ions enter the cell by
inding to the phosphorus and nitrogen groups of DNA
trands, which causes damage to DNA by breaking the
trands and subsequently causing cell death [8,9].
In the present study, we focused on the biosynthesis
f extracellular AgNPs synthesized from the filamen-
ous fungus Penicillium  brevicompactum  (MTCC-1999).
he biosyntheses of several nanoparticles were charac-
erized to determine their potential antibacterial effects
nd synergistic effects with antibiotics (e.g., tetracycline,
atifloxacin, and vancomycin). These nanoparticles
ere also tested for their anticancer activity against the
CF-7 breast cancer cell line by utilizing the MTT assay.
.  Material  and  methods
.1.  Collection  of  samples
The fungal strain P.  brevicompactum  (MTCC-1999)
as obtained from the Institute of Microbial Technol-
gy (IMTECH) in Chandigarh, India and subcultured on
otato dextrose agar media (PDA) to regulate its activity
or the duration of the study. The subcultures were per-
ormed under strict laboratory conditions. A fresh fungal
ulture was prepared as needed for the duration of the
tudy..2.  Biosynthesis  of  silver  nanoparticles
P.  brevicompactum  (MTCC-1999) fungal species
as utilized for the production of silver nanoparticles.sity for Science 10 (2016) 614–620 615
Biomass production was carried out by growing the
fungal strain in aerobic conditions [in a 250-ml flask
containing 100 ml of potato dextrose broth (PDB)] at
30 ◦C for 72 h in a shaker. After incubation, the biomass
of the fungal strain was collected by filtering the media
through Whatman filter paper No.1. The biomass was
then washed with sterile distilled water to remove any
remnants of the media. The resulting clean and fresh
biomass of the fungal strains were taken into the 200-ml
flasks containing 100 ml of deionized Milli-Q water,
mixed thoroughly, and then kept in a shaker for incuba-
tion at 30 ◦C for 72 h at 150 rpm. After 72 h of incubation,
clean and fresh biomass was sonicated and filtered
through Whatman filter paper No.1. The cell filtrate
was used for the production of the nanoparticles. Then,
1 mM AgNO3 prepared in 50 ml of Milli-Q water was
mixed with 50 ml of the cell filtrate extract, agitated, and
kept in a shaker at 30 ◦C in the dark overnight. Fun-
gal cell filtrate without silver nitrate (which served as
a control) was maintained along with the experimental
flask.
2.3.  Characterization  of  silver  nanoparticles
When a change in the colour of the cell filtrate upon
addition of silver nitrate was observed, that absorbance
was measured using a UV–visible spectrophotometer.
A sample of 1 ml was taken after 24 h, and the max-
imum absorbance was measured with the reference
range between 300 and 600 nm. FTIR was used to
analyze possible functional groups, biomolecules, and
proteins that play an important role in the reduction
of AgNO3 to AgNPs. Additionally, other molecules
that are involved in the stabilization of nanoparticles
were used as capping agents in the P.  brevicompactum
(MTCC-1999) cell filtrate extract. For FTIR analysis,
dried powder from AgNPs was mixed with potassium
bromide (KBr), and the dried pellet was analyzed using
the infrared spectra at a wavelength range of 500–
4000 cm−1.
AFM analysis was used to check the particle size and
shape of the nanoparticles. For AFM analysis, each sam-
ple was sonicated for 10 min, followed by centrifugation
at 15,000 rpm for 10 min. Then, a small thin film of the
pellet on a glass slide was prepared and examined under
a microscope.samples were prepared by placing a drop of the AgNP
suspension on a carbon-coated copper grid and allow-
ing the samples to evaporate inside a vacuum dryer. The
samples were then scanned at a high resolution.
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trophotometry, which showed a peak absorption at
420 nm due to the interband transition and plasmon
vibration of the nanoparticles (Fig. 2) [11,12]. Those616 S. Majeed et al. / Journal of Taibah
2.4.  Antimicrobial  activity
Biologically synthesized AgNPs using P.  brevicom-
pactum (MTCC-1999) were used to check for its
antibacterial activity by the disc diffusion method. The
antimicrobial activities of the AgNPs were tested against
several isolated pathogenic bacteria: Staphylococcus
epidermidis,  Staphylococcus  aureus,  Vibro  cholerae,
Proteus vulgaris, and Escherichia  coli. Furthermore, to
determine if there was a synergistic effect, the AgNPs
were evaluated with antibiotics such as tetracycline,
gatifloxacin and vancomycin. The inhibition zone was
measured after overnight incubation at 37 ◦C [10].
2.5.  Anticancer  assay  of  silver  nanoparticles
The anticancer effect of AgNPs on MCF-7
breast cancer cells was determined using MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) colorimetric technique (National Institute of
Cell Science (NICS), Poona). The AgNPs were first
weighed, and the required nanoparticles solution was
prepared in sterile double-distilled water and diluted
to the required concentrations (10, 30, 50, 70, 90,
and 110 g/mL) using the cell culture medium. The
required concentrations of AgNPs were then added
to the cell cultures to obtain the final concentration
of AgNPs and incubated for 24 and 48 h at 37 ◦C.
Cells treated without the nanoparticles were used as
controls. After 24 and 48 h of incubation, the cells
were washed with phosphate buffer solution, and
then 100 L of the yellow tetrazolium MTT solution
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) was added to each microtiter well. Microtiter
plates were incubated for 2–3 h at 37 ◦C for the reduction
of the MTT dye (NADH to NADPH) by normal living
cells. Then, 100 L of DMSO was added to the each
well to solubilize the MTT crystals. These plates were
kept in a shaker for 10–15 min to allow for complete
crystal formation so that the crystals could solubilize
properly. The cytotoxicity effect on MCF-7 cells was
detected by eluting the dye with DMSO, and the
optical density was measured using spectrophotometer.
Optical density (OD) values were read at 595 nm. All
experiments were performed in triplicates. A cell control
and sample were included in each assay to compare
the full cell viability after cytotoxicity. The percentage
of cell viability was calculated using the following
formula:
% Cell viability = Mean OD of sample
OD cell control
× 100Fig. 1. Synthesis of silver nanoparticles from P. brevicompactum
(MTCC-1999). (A) Before AgNO3. (B) After AgNO3.
3.  Results  and  discussion
For the current study, the fungus P.  brevicom-
pactum  (MTCC-1999) was utilized for the extracellular
biosynthesis of AgNPs, and 1 mM AgNO3 was added to
the cell-free filtrate. The solution colour changes to dark
brown indicating nanoparticle formation (Fig. 1). These
nanoparticles were further analyzed by UV–visible spec-Fig. 2. UV analysis of AgNPs synthesized from P. brevicompactum
(MTCC-1999). Absorption peak of cell filtrate with AgNPs (A) and
cell filtrate without AgNPs (B).
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bservations are consistent with the qualitative analysis
f silver nanoparticles.
The FTIR analysis was used for the characterization
f AgNPs in cell filtrate extract from P.  brevicom-
actum (MTCC-1999). The IR analysis showed the
ollowing: the sharp peaks at 3425.4 cm−1 were indica-
ive of the N H stretching of amides, the peak at
643.2 cm−1 were attributed to the N H bending of
mines, the peak at 1380.9 cm−1 was ascribed to the
O2 asymmetric stretching of nitro compounds, and the
eak at 1080 cm−1 was attributed to the C N stretch-
ng of amines. Certain small peaks were observed at
64.4 cm−1 (N H wag of amines), 617.17 cm−1 (C Cl
tretch of alkyl halides) and 540.02 cm−1 (C Br stretch
f alkyl halides). Sharp and prominent broad peaks
howed that amide and amine bonding was involved in
he capping of silver nanoparticles, which play an impor-
ant role in stabilizing nanoparticles. However, there
ere some weak peaks (864.4 cm−1, 617.17 cm−1, and
40.02 cm−1), which were negligible and not observed
s prominent groups (see Fig. 3).
ig. 4. AFM analysis of AgNPs. (A) 2D image of the AgNP horizontal cross
nalysis showing average particle size.Fig. 3. FTIR spectra of AgNPs synthesized from P. brevicampactum.
AFM analysis was used to check the particle size
of nanoparticles. A two-dimensional horizontal cross
section of the AgNPs indicated that the nanoparti-
cles were well defined, spherical, and between 30 and
50 nm in size. A histogram analysis revealed that the
average particle size was approximately 40 nm. The
three-dimensional image showed the average roughness
 section. (B) Line profiling. (C) 3D image of AgNPs. (D) Histogram
618 S. Majeed et al. / Journal of Taibah University for Science 10 (2016) 614–620
Fig. 5. HR-TEM transmission analysis of AgNPs synthesized from P. brevicompactum (MTCC-1999).
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antibacterial activity alone and also in combination withFig. 6. Graphical representation of synergistic effects of AgNPs with
tetracycline and gatifloxacin.
and inhomogeneity of the cluster formation of nanopar-
ticles (Fig. 4).
TEM analysis revealed that the average size of the
AgNPs was between 30 and 45 nm, and the small
particles were well-dispersed and spherical in mor-
phology, as shown in Fig. 5. The selected area of the
electron diffraction pattern showed continuous ring pat-
terns which originated from the polycrystalline state.
This observation indicated that there were crystallites
that attached to the surface of single AgNPs.
Table 1
Inhibition zone (mM) of tetracycline, gatifloxacin and vancomycin against ba
S No. Pathogens Filterate AgNPs Tet Tet + Ag
1. S. epidermidis 8 ± 0.86 14 ± 0.94 13 ± 0.23 19 ± 0.0
2. S. aureus 7 ± 0.34 12 ± 0.24 15 ± 0.08 20 ± 0.3
3. V. cholerae 8 ± 0.42 12 ± 0.26 14 ± 1.02 18 ± 0.7
4. E. coli 8 ± 0.14 16 ± 0.34 18 ± 0.12 22 ± 0.1
5. P. vulgaris 9 ± 0.34 14 ± 0.03 16 ± 0.52 19 ± 1.0
Tet – tetracycline, Gat – gatifloxacin, Van – vancomycin.Fig. 7. Graphical representation of synergistic effect of AgNPs with
vancomycin.
Antibacterial analysis of AgNPs synthesized from P.
brevicampactum was checked against S.  epidermidis,  V.
cholerae, E.  coli,  S.  aureus, and P.  vulgaris  by the disc
diffusion method. Each disc was impregnated with 30 g
of AgNPs to carry out the investigation. Each antibiotic
disc of tetracycline and gatifloxacin was evaluated alone
and in combination with the nanoparticles (antibiotic
discs were impregnated with 15 g/disc of nanopar-
ticles to determine the synergistic effects against the
bacterial pathogens). The synthesized AgNPs showed
good antibacterial activity. Antibiotics showed goodAgNPs, with a high antimicrobial property rating, as
shown in Table 1 [13]. In the case of gatifloxacin,
cterial pathogens in absence and presence of silver nanoparticles.
NPs Gat Gat + AgNPs Van Van + Agnps
8 23 ± 0.38 31 ± 0.92 23 ± 016 29 ± 0.66
8 21 ± 0.46 28 ± 1.12 18 ± 1.44 26 ± 084
7 20 ± 0.32 29 ± 0.54 21 ± 0.44 30 ± 0.90
2 28 ± 0.86 35 ± 0.16 19 ± 0.8 25 ± 0.36
4 26 ± 0.12 32 ± 0.23 21 ± 0.32 31 ± 0.12
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(ig. 8. Anticancer activity of AgNPs against MCF-7 breast cancer cel
n the cell morphology.
he presence of AgNPs in the highest zone of inhibi-
ion was observed with E.  coli  (35 mM) followed by
. vulgaris  (32 mM). For tetracycline, highest zone of
nhibition was observed with E.  coli  (22 mM) followed
y S.  aureus  (20 mM). For vancomycin, the highest zone
f inhibition was observed with P.  vulgaris  (31 mM)
ollowed by V.  cholerae  (30 mM). Each experimental
rocedure was repeated three times, and the standard
eviation (SD) was applied to calculate the average val-
es. Figs. 6 and 7 show the graphical representation of
he combined effects of AgNPs with tetracycline, gati-
oxacin, and vancomycin [14].
The exact mechanism of how nanoparticles inhibit the
rowth of bacteria is not yet known, but several hypothe-
es indicate that silver nanoparticles attack the enzymes
resent inside the bacteria, which causes morphological
hanges that lead to DNA damage. This DNA damage
ould result from the production of free radicals, which
ttack the phosphorus groups of DNA and eventually
nhibits the growth of bacteria [13].
An anticancer analysis (via MTT assay) was carried
ut to check the efficacy of AgNPs on MCF-7 cancer
ells. These AgNPs showed a concentration-dependent
nticancer effect on MCF-7 cells. The IC50 value was
0 g/ml after 24 h of incubation. Upon further incuba-
ion for 48 h, the toxicity increased and the IC50 value
as 50 g/ml, as shown in Fig. 8. Similar observations
ere previously reported by other investigators [15,16].
hus, these nanoparticles display anticancer activity
gainst MCF-7 breast cancer cells and can be used as
nticancer and antibacterial agents. However, animal
tudies are needed to determine the in vivo toxicity of
gNPs before clinical applications can be considered..  Conclusions
AgNPs synthesized from fungi P.  brevicompactum
MTCC-1999) display antibacterial activity against) Before treatment of AgNPs. (B) After treatment of AgNPs. Change
clinically isolated bacterial pathogens and also enhance
the antibacterial activity of antibiotics. These nanopar-
ticles also display anticancer activity against MCF-7
breast cancer cells, which suggests that AgNPs could
also be used as anticancer agents. To that end, further
cytotoxicity studies and animal trials have to be carried
out before considering the clinical use of AgNPs.
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